Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Questions Remain For Samsung Bioepis Post-Biogen
Management Changes, Strategic Focus And Structural Aspects Yet To Be Decided
Feb 08 2022
•
By
David Wallace
The future path for Samsung Bioepis is not yet fully decided • Source: Cagkan Sayin / Alamy Stock Photo
More from Biosimilars
More from Products